Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$13.38
+0.5%
$13.08
$5.93
▼
$14.71
$2.92B1.952.03 million shs1.87 million shs
CorVel Corp. stock logo
CRVL
CorVel
$83.87
0.0%
$72.95
$44.83
▼
$84.56
$4.28B1.05215,877 shs140,995 shs
OPKO Health, Inc. stock logo
OPK
OPKO Health
$1.63
$1.54
$0.98
▼
$1.77
$1.22B1.513.22 million shs1.80 million shs
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$22.41
-2.1%
$20.81
$18.92
▼
$28.82
$2.86B0.81.05 million shs669,353 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
+2.54%+5.38%+0.76%+40.95%+40.51%
CorVel Corp. stock logo
CRVL
CorVel
+3.93%+4.47%+13.98%+40.13%+10.56%
OPKO Health, Inc. stock logo
OPK
OPKO Health
+1.87%+1.24%-5.78%+33.61%+7.95%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
+1.87%+1.19%+17.63%-10.24%-11.86%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$13.38
+0.5%
$13.08
$5.93
▼
$14.71
$2.92B1.952.03 million shs1.87 million shs
CorVel Corp. stock logo
CRVL
CorVel
$83.87
0.0%
$72.95
$44.83
▼
$84.56
$4.28B1.05215,877 shs140,995 shs
OPKO Health, Inc. stock logo
OPK
OPKO Health
$1.63
$1.54
$0.98
▼
$1.77
$1.22B1.513.22 million shs1.80 million shs
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$22.41
-2.1%
$20.81
$18.92
▼
$28.82
$2.86B0.81.05 million shs669,353 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
+2.54%+5.38%+0.76%+40.95%+40.51%
CorVel Corp. stock logo
CRVL
CorVel
+3.93%+4.47%+13.98%+40.13%+10.56%
OPKO Health, Inc. stock logo
OPK
OPKO Health
+1.87%+1.24%-5.78%+33.61%+7.95%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
+1.87%+1.19%+17.63%-10.24%-11.86%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
2.75
Moderate Buy$14.065.05% Upside
CorVel Corp. stock logo
CRVL
CorVel
2.00
HoldN/AN/A
OPKO Health, Inc. stock logo
OPK
OPKO Health
2.63
Moderate Buy$2.9681.75% Upside
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
2.79
Moderate Buy$31.0038.33% Upside

Current Analyst Ratings Breakdown

Latest OPK, CRVL, AVAH, and PRVA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/16/2026
OPKO Health, Inc. stock logo
OPK
OPKO Health
Set Price Target$4.00
10/16/2026
OPKO Health, Inc. stock logo
OPK
OPKO Health
Reiterated RatingBuy
10/16/2026
OPKO Health, Inc. stock logo
OPK
OPKO Health
Reiterated RatingBuy
10/16/2026
OPKO Health, Inc. stock logo
OPK
OPKO Health
Reiterated RatingOverweight$3.00 ➝ $4.00
10/16/2026
OPKO Health, Inc. stock logo
OPK
OPKO Health
UpgradeMarket Perform ➝ Outperform$2.25
10/14/2026
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
UpgradeHold (C+) ➝ Buy (B-)
9/29/2026
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Reiterated RatingHold (C+)
9/29/2026
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
Reiterated RatingHold (C)
9/28/2026
OPKO Health, Inc. stock logo
OPK
OPKO Health
UpgradeHold ➝ Strong-Buy
9/14/2026
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Boost Price TargetNeutral$8.00 ➝ $15.00
9/1/2026
CorVel Corp. stock logo
CRVL
CorVel
UpgradeHold (C-) ➝ Hold (C)
(Data available from 10/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$2.43B1.20$0.71 per share18.84$0.93 per share14.39
CorVel Corp. stock logo
CRVL
CorVel
$958.53M4.46$2.89 per share29.05$7.71 per share10.88
OPKO Health, Inc. stock logo
OPK
OPKO Health
$606.90M2.00N/AN/A$1.67 per share0.98
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$2.12B1.35$0.27 per share84.20$6.43 per share3.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$225.03M$1.2310.8815.380.8010.56%80.70%7.42%11/5/2026 (Estimated)
CorVel Corp. stock logo
CRVL
CorVel
$110.34M$2.2537.28N/AN/A11.72%29.92%17.82%11/3/2026 (Estimated)
OPKO Health, Inc. stock logo
OPK
OPKO Health
-$225.68M-$0.09N/AN/AN/A-12.40%-5.88%-3.83%11/4/2026 (Estimated)
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$22.92M$0.21106.7254.66N/A1.19%3.52%2.00%11/5/2026 (Estimated)

Latest OPK, CRVL, AVAH, and PRVA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$0.2073N/AN/AN/A$679.51 millionN/A
11/5/2026Q3 2026
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$0.0906N/AN/AN/A$610.74 millionN/A
11/4/2026Q3 2026
OPKO Health, Inc. stock logo
OPK
OPKO Health
-$0.07N/AN/AN/A$136.62 millionN/A
8/13/2026Q2 2026
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$0.1683$0.22+$0.0517$0.18$638.61 million$670.48 million
8/6/2026Q2 2026
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$0.0674$0.19+$0.1226$0.07$597.33 million$632.63 million
8/4/2026Q1 2027
CorVel Corp. stock logo
CRVL
CorVel
N/A$0.63N/A$0.63N/A$259.93 million
7/27/2026Q2 2026
OPKO Health, Inc. stock logo
OPK
OPKO Health
-$0.08-$0.01+$0.07-$0.01$131.23 million$163.58 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/AN/AN/AN/AN/A
CorVel Corp. stock logo
CRVL
CorVel
N/AN/AN/AN/AN/A
OPKO Health, Inc. stock logo
OPK
OPKO Health
N/AN/AN/AN/AN/A
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
4.47
1.16
1.16
CorVel Corp. stock logo
CRVL
CorVel
N/A
1.94
1.94
OPKO Health, Inc. stock logo
OPK
OPKO Health
0.28
3.35
2.93
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
N/A
1.62
1.62

Institutional Ownership

CompanyInstitutional Ownership
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
87.96%
CorVel Corp. stock logo
CRVL
CorVel
51.36%
OPKO Health, Inc. stock logo
OPK
OPKO Health
64.63%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
94.48%

Insider Ownership

CompanyInsider Ownership
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
5.30%
CorVel Corp. stock logo
CRVL
CorVel
39.72%
OPKO Health, Inc. stock logo
OPK
OPKO Health
44.72%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
5.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
35,500218.22 million206.65 millionOptionable
CorVel Corp. stock logo
CRVL
CorVel
5,23951.01 million30.75 millionOptionable
OPKO Health, Inc. stock logo
OPK
OPKO Health
1,373746.33 million412.57 millionOptionable
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
1,226127.73 million120.45 millionOptionable

Recent News About These Companies

Privia Health stock reports strong Q2 growth and guidance
Privia Health Group Inc (PRVA)
Why Privia Health Group (PRVA) Is Getting Attention Now
Truist Financial Remains a Buy on Privia Health Group (PRVA)
Privia Health Group (PRVA) Gets a Buy from Citi
Evercore ISI Remains a Buy on Privia Health Group (PRVA)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aveanna Healthcare stock logo

Aveanna Healthcare NASDAQ:AVAH

$13.38 +0.06 (+0.45%)
Closing price 04:00 PM Eastern
Extended Trading
$13.40 +0.02 (+0.15%)
As of 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

CorVel stock logo

CorVel NASDAQ:CRVL

$83.87 -0.01 (-0.01%)
Closing price 04:00 PM Eastern
Extended Trading
$83.90 +0.02 (+0.03%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.

OPKO Health stock logo

OPKO Health NASDAQ:OPK

$1.63 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.62 -0.01 (-0.86%)
As of 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.

Privia Health Group stock logo

Privia Health Group NASDAQ:PRVA

$22.41 -0.48 (-2.10%)
Closing price 04:00 PM Eastern
Extended Trading
$22.42 +0.01 (+0.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.